| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 42385-985-01 | 42385-985 | HUMAN PRESCRIPTION DRUG | Oseltamivir | Oseltamivir phosphate | CAPSULE | ORAL | 20240502 | N/A | ANDA | ANDA218565 | Laurus Labs Limited | OSELTAMIVIR PHOSPHATE | 30 mg/1 | 100 CAPSULE in 1 BOTTLE (42385-985-01) |
| 42385-985-11 | 42385-985 | HUMAN PRESCRIPTION DRUG | Oseltamivir | Oseltamivir phosphate | CAPSULE | ORAL | 20240502 | N/A | ANDA | ANDA218565 | Laurus Labs Limited | OSELTAMIVIR PHOSPHATE | 30 mg/1 | 1 BLISTER PACK in 1 CARTON (42385-985-11) / 10 CAPSULE in 1 BLISTER PACK (42385-985-10) |
| 42385-986-01 | 42385-986 | HUMAN PRESCRIPTION DRUG | Oseltamivir | Oseltamivir phosphate | CAPSULE | ORAL | 20240502 | N/A | ANDA | ANDA218565 | Laurus Labs Limited | OSELTAMIVIR PHOSPHATE | 45 mg/1 | 100 CAPSULE in 1 BOTTLE (42385-986-01) |
| 42385-986-11 | 42385-986 | HUMAN PRESCRIPTION DRUG | Oseltamivir | Oseltamivir phosphate | CAPSULE | ORAL | 20240502 | N/A | ANDA | ANDA218565 | Laurus Labs Limited | OSELTAMIVIR PHOSPHATE | 45 mg/1 | 1 BLISTER PACK in 1 CARTON (42385-986-11) / 10 CAPSULE in 1 BLISTER PACK (42385-986-10) |
| 42385-987-01 | 42385-987 | HUMAN PRESCRIPTION DRUG | Oseltamivir | Oseltamivir phosphate | CAPSULE | ORAL | 20240502 | N/A | ANDA | ANDA218565 | Laurus Labs Limited | OSELTAMIVIR PHOSPHATE | 75 mg/1 | 100 CAPSULE in 1 BOTTLE (42385-987-01) |
| 42385-987-11 | 42385-987 | HUMAN PRESCRIPTION DRUG | Oseltamivir | Oseltamivir phosphate | CAPSULE | ORAL | 20240502 | N/A | ANDA | ANDA218565 | Laurus Labs Limited | OSELTAMIVIR PHOSPHATE | 75 mg/1 | 1 BLISTER PACK in 1 CARTON (42385-987-11) / 10 CAPSULE in 1 BLISTER PACK (42385-987-10) |